Strategic Assessment: CARING FOR YOU PTS LIMITED

1. Executive Summary

Caring For You PTS Limited, a patient transport operator with a two-decade trading history, has entered liquidation following a catastrophic deterioration in its financial position between 2014 and 2015. The company's net assets swung from a positive £116,899 to negative £339,381 in a single year, representing a £456,000 erosion of shareholder value that rendered the business insolvent and unable to continue as a going concern despite the director's stated support.

2. Strategic Assets

Historical Market Position: Operating in SIC code 49390 (Other passenger land transport), the company likely served the patient transport services (PTS) niche—a specialized segment requiring regulatory compliance and clinical governance capabilities. This positioning, underpinned by its 20-year trading history since 1995, would have provided institutional knowledge and client relationships.

Tangible Asset Base: The company maintained a fleet of vehicles with a net book value of £176,319 (down from £219,369), representing the core operational infrastructure for passenger transport. However, the significant depreciation charge of £58,456 against minimal additions (£33,820) indicates underinvestment in fleet renewal—a critical strategic failing in an asset-intensive service business.

Minimal Capital Structure: With only £52 in issued share capital across three share classes, the company was woefully undercapitalized from inception, leaving it structurally vulnerable to any operational disruption or contract loss.

3. Growth Opportunities

Market Context—Unrealized: The UK patient transport market benefits from demographic tailwinds (aging population, increasing NHS outsourcing). However, this company's financial deterioration suggests it was unable to capitalize on these structural demand drivers.

Contract Portfolio—Revenue Concentration Risk: The dramatic debtor decline from £644,674 to £405,588 likely signals lost contracts or delayed payments from commissioning authorities. In the PTS sector, reliance on a small number of local authority or clinical commissioning group contracts creates existential concentration risk.

No Viable Path Forward: The company's liquidation status eliminates any organic or acquisitive growth thesis. Any residual value lies solely in the liquidation of tangible assets and debt collection.

4. Strategic Risks

Terminal Insolvency: Net liabilities of £339,381 against total assets of £418,091 create a deep solvency deficit. Current liabilities of £816,559 dwarf current assets of £418,091, producing net current liabilities of £398,468—a liquidity position that made continued trading impossible.

Cash Collapse: Cash reserves evaporated from £86,689 to £12,503 (an 86% decline), eliminating any operational buffer and likely triggering creditor actions that precipitated liquidation.

Director Dependency and Governance Failure: The company operated with a single director (Mr. J D Donovan) holding significant influence, with an unsecured director's loan outstanding. The overdue filing status for both accounts and confirmation statements signals governance breakdown coinciding with financial distress—a correlation we observe frequently in failing enterprises.

Secured Creditor Exposure: Creditors include £217,859 with security, indicating asset encumbrance that will severely limit recovery values for unsecured creditors in liquidation.

Working Capital Mismanagement: The swing from net current assets of £16,797 to net current liabilities of £398,468 in one year represents a £415,000 working capital deterioration, suggesting either a major contract loss, bad debt write-off, or operational crisis that management could not arrest.